172@29@16@137!~!172@29@0@53!~!|commonstore|commonfiles|moneycontrol_header.php?cid=0&s_cid=0&radar_off=0&is_revamped_header=0&is_responsive=1&sec=PNC_FINANCIAL&priceinter=1&frommc=1!~!|commonstore|commonfiles|moneycontrol_header.php

Network18 Presents

partnered by

  • Galaxy Note20 | 20 Ultra
Moneycontrol
SENSEX NIFTY

Network18 Presents

  • partnered by
  • Galaxy Note20 | 20 Ultra
you are here:

Vivimed Labs Ltd.

BSE: 532660 | NSE: VIVIMEDLAB |

Shares falling in the `Trade-to-Trade` or `T-segment` are traded in this series and no intraday is allowed. This means trades can only be settled by accepting or giving the delivery of shares.
Series: BE | ISIN: INE526G01021 | SECTOR: Pharmaceuticals

BSE Live

Aug 14, 14:50
16.80 0.80 (5.00%)
Volume
AVERAGE VOLUME
5-Day
321,998
10-Day
167,029
30-Day
68,203
90,435
  • Prev. Close

    16.00

  • Open Price

    16.80

  • Bid Price (Qty.)

    16.80 (58918)

  • Offer Price (Qty.)

    0.00 (0)

NSE Live

Aug 14, 14:50
16.70 0.75 (4.70%)
Volume
AVERAGE VOLUME
5-Day
331,991
10-Day
193,742
30-Day
104,091
114,251
  • Prev. Close

    15.95

  • Open Price

    16.70

  • Bid Price (Qty.)

    16.70 (199559)

  • Offer Price (Qty.)

    0.00 (0)

Financials

2019 2018 2017 2016 2015
Half Yearly Results of Vivimed Labs (in Rs. Cr.) Mar '20 Sep '19 Mar '19 Sep '18 Mar '18  
Net Sales/Income from operations 117.87 158.74 126.32 125.49 133.88  
Other Operating Income -- -- -- -- --  
Total Income From Operations 117.87 158.74 126.32 125.49 133.88  
EXPENDITURE  
Consumption of Raw Materials 67.11 88.06 58.14 69.56 65.28  
Purchase of Traded Goods -- -- -- -- --  
Increase/Decrease in Stocks -4.41 -0.46 -19.27 -28.14 -21.46  
Power & Fuel -- -- -- -- --  
Employees Cost 17.12 14.74 20.97 16.91 17.95  
Depreciation 8.09 8.48 9.01 9.25 8.74  
Excise Duty -- -- -- -- --  
Admin. And Selling Expenses -- -- -- -- --  
R & D Expenses -- -- -- -- --  
Provisions And Contingencies -- -- -- -- --  
Exp. Capitalised -- -- -- -- --  
Other Expenses 27.88 34.27 33.44 32.94 33.65  
P/L Before Other 2.08 13.64 24.03 24.97 29.72  
Other Income 2.90 3.63 7.81 0.73 1.58  
P/L Before Int. 4.98 17.27 31.84 25.70 31.30  
Interest 21.87 21.13 29.45 22.95 26.68  
P/L Before Exceptional Items & Tax -16.89 -3.85 2.39 2.74 4.62  
Exceptional Items -- -- -- -- --  
P/L Before Tax -16.89 -3.85 2.39 2.74 4.62  
Tax -0.61 -0.96 -1.19 0.23 -1.85  
P/L After Tax from Ordinary Activities -16.28 -2.89 3.58 2.51 6.47  
Prior Year Adjustments -- -- -- -- --  
Extra Ordinary Items -- -- -- -- --  
Net Profit/(Loss) For the Period -16.28 -2.89 3.58 2.51 6.47  
Equity Share Capital 16.58 16.58 16.50 16.50 16.50  
Reserves Excluding Revaluation Reserves -- -- -- -- --  
Equity Dividend Rate (%) -- -- -- -- --  
EPS Before Extra Ordinary  
Basic EPS -1.96 -0.35 -- 0.30 --  
Diluted EPS -- -0.34 -- 0.29 --  
EPS After Extra Ordinary  
Basic EPS. -1.96 -0.35 -- 0.30 --  
Diluted EPS. -- -0.34 -- 0.29 --  
Public Share Holding  
No Of Shares (Crores) -- -- -- -- --  
Share Holding (%) -- -- -- -- --  
Promoters and Promoter Group Shareholding  
a) Pledged/Encumbered  
- Number of shares (Crores) -- -- -- -- --  
- Per. of shares (as a % of the total sh. of prom. and promoter group) -- -- -- -- --  
- Per. of shares (as a % of the total Share Cap. of the company) -- -- -- -- --  
b) Non-encumbered  
- Number of shares (Crores). -- -- -- -- --  
- Per. of shares (as a % of the total sh. of prom. and promoter group). -- -- -- -- --  
- Per. of shares (as a % of the total Share Cap. of the company). -- -- -- -- --  
Source : Dion Global Solutions Limited